Literature DB >> 8318385

Ruptured abdominal aortic aneurysms in a private hospital: a decade's experience (1980-1989).

R A McCready1, H Siderys, J N Pittman, G T Herod, H G Halbrook, J W Fehrenbacher, D J Beckman, D A Hormuth, D Nelson.   

Abstract

Despite refinements in elective resection of abdominal aortic aneurysms, morbidity and mortality rates for ruptured abdominal aortic aneurysms (RAAAs) remain high. Between January 1, 1980 and December 31, 1989, we treated 208 patients with RAAAs whose mean age was 70 years. The overall mortality rate was 49.5%. Logistic regression analysis showed that three factors correlated with predicted patient survival. Patients < 70 years old had a survival rate of 65.7% compared with a survival rate of 37.4% in patients > 70 years old (p < 0.001). Among "stable" patients (preoperative blood pressure consistently > 90 mm Hg), 88.9% survived compared with 40.9% of "unstable" patients (blood pressure < 90 mm Hg) (p < 0.001). Of the patients with free intraperitoneal rupture, 38.3% survived compared with a survival rate of 79.6% of patients with rupture confined to the retroperitoneum (p < 0.001). Despite a high overall mortality rate in patients with RAAAs, surgical intervention remains the only hope for survival. We continue to advocate an aggressive surgical approach in this group of patients.

Entities:  

Mesh:

Year:  1993        PMID: 8318385     DOI: 10.1007/BF02000246

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  Ruptured aortic aneurysm: the decision not to operate.

Authors:  D F Hewin; W B Campbell
Journal:  Ann R Coll Surg Engl       Date:  1998-05       Impact factor: 1.891

2.  A large proportion of patients with small ruptured abdominal aortic aneurysms are women and have chronic obstructive pulmonary disease.

Authors:  Antti Siika; Moritz Lindquist Liljeqvist; Sayid Zommorodi; Olga Nilsson; Patricia Andersson; T Christian Gasser; Joy Roy; Rebecka Hultgren
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.